Assembly Biosciences

ASMBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$424.015 M

$26.68 +0.87%

Close of 7 Aug 2026

Revenue

$72.3M

#2624 by revenue

Earnings

-$6.12M

Loss-making

Shares outstanding

15,862,705

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#217RezoluteRZLT$451.6M
#218Larimar TherapeuticsLRMR$432.2M
#219Assembly BiosciencesASMB$424.0M
#220Atea PharmaceuticalsAVIR$420.1M
#221KamadaKMDA$419.4M

Where these numbers come from

Share counts and financials for Assembly Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.